Rifampicin resistant tuberculosis in presumptive pulmonary tuberculosis cases in Dubti Hospital, Afar, Ethiopia | Zendy

Gebremedhin Bizayene Gebrehiwet | Zendy; Atsebeha Gebrekidan Kahsay | Zendy; Letemichael Negash Welekidan | Zendy; Amlsha Kahsay Hagos | Zendy; Getahun Kahsay Abay | Zendy; Dawit Gebreegziabiher Hagos | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Rifampicin resistant tuberculosis in presumptive pulmonary tuberculosis cases in Dubti Hospital, Afar, Ethiopia

Author(s) -

Gebremedhin Bizayene Gebrehiwet,

Atsebeha Gebrekidan Kahsay,

Letemichael Negash Welekidan,

Amlsha Kahsay Hagos,

Getahun Kahsay Abay,

Dawit Gebreegziabiher Hagos

Publication year - 2019

Publication title -

the journal of infection in developing countries

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.322

H-Index - 49

eISSN - 2036-6590

pISSN - 1972-2680

DOI - 10.3855/jidc.10462

Subject(s) - medicine , tuberculosis , rifampicin , sputum , drug resistance , logistic regression , multi drug resistant tuberculosis , population , isoniazid , cross sectional study , mycobacterium tuberculosis , environmental health , pathology , microbiology and biotechnology , biology

Ethiopia stood third in drug-resistant tuberculosis (TB) in Africa, and more than 5,000 MDR-TB patients are reported each year. Greater than 90% of rifampicin (RIF) resistant strains are resistant to isoniazid (INH) and hence the objective of this study was to determine the prevalence and risk factors of RIF resistant MTB among presumptive TB cases at Dubti General Hospital, Afar, Ethiopia.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research